Inventor
TAVARES FRANCIS X
US22 patents
⚠️ This page may combine multiple inventors who share the name “TAVARES FRANCIS X”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
G1 THERAPEUTICS INC
16 patentsUS10189849B2Jan 29, 2019
CDK inhibitors
G1 THERAPEUTICS INC18 citations97
US10189851B2Jan 29, 2019
CDK inhibitors
G1 THERAPEUTICS INC19 citations97
US9499564B2Nov 22, 2016
CDK inhibitors
G1 THERAPEUTICS INC34 citations97
US9481691B2Nov 1, 2016
CDK inhibitors
G1 THERAPEUTICS INC31 citations97
US9102682B2Aug 11, 2015
CDK inhibitors
G1 THERAPEUTICS INC42 citations97
US8829012B2Sep 9, 2014
CDK inhibitors
G1 THERAPEUTICS INC47 citations97
US8822683B2Sep 2, 2014
CDK inhibitors
G1 THERAPEUTICS INC55 citations97
US8691830B2Apr 8, 2014
CDK inhibitors
G1 THERAPEUTICS INC53 citations97
US8598186B2Dec 3, 2013
CDK inhibitors
G1 THERAPEUTICS INC81 citations97
US8598197B2Dec 3, 2013
CDK inhibitors
G1 THERAPEUTICS INC65 citations97
US10189850B2Jan 29, 2019
CDK inhibitors
G1 THERAPEUTICS INC17 citations94
US9957276B2May 1, 2018
CDK inhibitors
G1 THERAPEUTICS INC14 citations92
US11654148B2May 23, 2023
HSPC-sparing treatments for RB-positive abnormal cellular proliferation
G1 THERAPEUTICS INC4 citations86
US10927120B2Feb 23, 2021
CDK inhibitors
G1 THERAPEUTICS INC5 citations84
US10696682B2Jun 30, 2020
CDK inhibitors
G1 THERAPEUTICS INC6 citations84
US10660896B2May 26, 2020
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC5 citations84
NOVATARG INC
3 patentsUS11834411B2Dec 5, 2023
Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
NOVATARG INC2 citations66
US11261157B2Mar 1, 2022
Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
NOVATARG INC4 citations66
US12371404B2Jul 29, 2025
Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
NOVATARG INC0 citations56